ARS Pharmaceuticals, Inc.
Recent Filings
All 494 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G | — | Mar 24, 2026 |
| S-8 | S-8 | Mar 9, 2026 |
| 10-K | 10-K | Mar 9, 2026 |
| 8-K | 8-K | Mar 9, 2026 |
| SCHEDULE 13G | — | Feb 13, 2026 |
| SCHEDULE 13G | — | Jan 21, 2026 |
| 4 | — | Jan 5, 2026 |
| 4 | — | Jan 5, 2026 |
| 4 | — | Jan 5, 2026 |
| 4 | — | Jan 5, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Dorsey Brian | Chief Operating Officer | Sale | 21,828 @ $8.71 | 10,789 | Nov 13, 2025 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 @ $14.49 | 1,196,494 | Aug 21, 2025 |
| Scott Kathleen D. | Chief Financial Officer | Sale | 12,500 @ $15.00 | 10,042 | Aug 21, 2025 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 12,344 @ $14.03 | 1,285,103 | Aug 20, 2025 |
| Karas Eric | Chief Commercial Officer | Sale | 15,000 @ $16.99 | 10,315 | Jul 1, 2025 |
| Flynn James E | — | Sale | 370,075 @ $18.46 | 4,887,254 | Jun 27, 2025 |
| Fitzpatrick Alexander A | Chief Legal Officer | Sale | 102,969 @ $14.10 | 89,613 | May 20, 2025 |
| SAUNDERS BRENT L | — | Sale | 120,000 @ $14.25 | — | May 20, 2025 |
| Scott Kathleen D. | Chief Financial Officer | Sale | 50,000 @ $14.10 | 7,424 | May 20, 2025 |
| Shawver Laura | — | Sale | 50,002 @ $12.30 | 210,346 | Apr 7, 2025 |